Schubert & Co’s GE HealthCare GEHC Stock Holding History

Schubert & Co’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-26	Closed	-$2.13K	–	617
2023 Q1	$2.13K	Buy	+26	New	+$1.86K	﹤0.01%	888

Other funds holding GEHC

General Electric Evendale, Ohio $308M AUM 40.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Newport Trust Company Washington, District of Columbia $40.7B AUM 24.62% 1-Year Est. Return

Schubert & Co's GEHC Position: Q2 2023 in Review

Schubert & Co sold out of GE HealthCare (GEHC) in Q2 2023, closing a stake of 26 shares — an estimated $2.13K sold.

Schubert & Co first reported a position in GEHC in Q1 2023 and held it in 1 quarter. The position peaked at $2.13K in Q1 2023. 1,133 funds tracked by Wall St. Rank hold GEHC as of Q2 2023.

Schubert & Co reported no remaining GE HealthCare position as of Q2 2023 after selling out during the quarter.
Schubert & Co sold 26 GE HealthCare shares in Q2 2023, an estimated $2.13K.
Schubert & Co first reported a position in GE HealthCare in Q1 2023 and held it in 1 quarter.
Schubert & Co's GE HealthCare position peaked at $2.13K in Q1 2023.
1,133 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2023.

Based on Schubert & Co's 13F filing for Q2 2023, filed 4 Aug 2023.